Medicine:INNA-051
From HandWiki
Short description: Vaccine candidate against COVID-19
| Vaccine description | |
|---|---|
| Target disease | SARS-CoV-2 |
| Type | viral |
| Clinical data | |
| Routes of administration | Intranasal |
INNA-051 is a COVID-19 vaccine candidate developed by Ena Respiratory.[1][2]
References
- ↑ "INNA-051 intranasal safety and tolerability study". 21 April 2021. https://www.anzctr.org.au/Trial/Registration/TrialReview.aspx?id=381625&isReview=true.
- ↑ Clinical trial number NCT05118763 for "Intranasal INNA-051 for Prevention of COVID-19 in Adults" at ClinicalTrials.gov
 |
